These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 27179253)

  • 41. Stepped Wedge Cluster Randomized Trials: A Methodological Overview.
    Li F; Wang R
    World Neurosurg; 2022 May; 161():323-330. PubMed ID: 35505551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving pragmatic clinical trial design using real-world data.
    Shortreed SM; Rutter CM; Cook AJ; Simon GE
    Clin Trials; 2019 Jun; 16(3):273-282. PubMed ID: 30866672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.
    Forbes G; Loudon K; Treweek S; Taylor SJC; Eldridge S
    J Clin Epidemiol; 2017 Oct; 90():119-126. PubMed ID: 28629699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
    Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
    Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.
    Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S
    Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sample size determination for stepped wedge cluster randomized trials in pragmatic settings.
    Wang J; Cao J; Zhang S; Ahn C
    Stat Methods Med Res; 2021 Jul; 30(7):1609-1623. PubMed ID: 34139916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential bias and lack of generalizability in electronic health record data: reflections on health equity from the National Institutes of Health Pragmatic Trials Collaboratory.
    Boyd AD; Gonzalez-Guarda R; Lawrence K; Patil CL; Ezenwa MO; O'Brien EC; Paek H; Braciszewski JM; Adeyemi O; Cuthel AM; Darby JE; Zigler CK; Ho PM; Faurot KR; Staman KL; Leigh JW; Dailey DL; Cheville A; Del Fiol G; Knisely MR; Grudzen CR; Marsolo K; Richesson RL; Schlaeger JM
    J Am Med Inform Assoc; 2023 Aug; 30(9):1561-1566. PubMed ID: 37364017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.
    Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S
    Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol.
    Lauffenburger JC; Isaac T; Trippa L; Keller P; Robertson T; Glynn RJ; Sequist TD; Kim DH; Fontanet CP; Castonguay EWB; Haff N; Barlev RA; Mahesri M; Gopalakrishnan C; Choudhry NK
    Implement Sci; 2021 Jan; 16(1):9. PubMed ID: 33413494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influential methods reports for group-randomized trials and related designs.
    Murray DM
    Clin Trials; 2022 Aug; 19(4):353-362. PubMed ID: 34991379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
    Kim SY; Flory J; Relton C
    Clin Trials; 2018 Feb; 15(1):9-16. PubMed ID: 29224380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stakeholder Engagement in Pragmatic Clinical Trials: Emphasizing Relationships to Improve Pain Management Delivery and Outcomes.
    Bastian LA; Cohen SP; Katsovich L; Becker WC; Brummett BR; Burgess DJ; Crunkhorn AE; Denneson LM; Frank JW; Goertz C; Ilfeld B; Kanzler KE; Krishnaswamy A; LaChappelle K; Martino S; Mattocks K; McGeary CA; Reznik TE; Rhon DI; Salsbury SA; Seal KH; Semiatin AM; Shin MH; Simon CB; Teyhen DS; Zamora K; Kerns RD;
    Pain Med; 2020 Dec; 21(Suppl 2):S13-S20. PubMed ID: 33313726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations When Designing and Implementing Pragmatic Clinical Trials That Include Older Hispanics.
    Samper-Ternent R; Silveira SL; Stevens A; Volpi E; Naik AD
    Ethn Dis; 2023 Apr; 33(2-3):76-83. PubMed ID: 38845738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs.
    Taljaard M; Teerenstra S; Ivers NM; Fergusson DA
    Clin Trials; 2016 Aug; 13(4):459-63. PubMed ID: 26940696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HELP! Problems in executing a pragmatic, randomized, stepped wedge trial on the Hospital Elder Life Program to prevent delirium in older patients.
    Heim N; van Stel HF; Ettema RG; van der Mast RC; Inouye SK; Schuurmans MJ
    Trials; 2017 May; 18(1):220. PubMed ID: 28514964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.
    Vanderhout S; Fergusson DA; Cook JA; Taljaard M
    PLoS Med; 2022 Feb; 19(2):e1003896. PubMed ID: 35134080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incorporating pragmatic features into power analysis for cluster randomized trials with a count outcome.
    Li D; Zhang S; Cao J
    Stat Med; 2020 Nov; 39(27):4037-4050. PubMed ID: 33165949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.